Adverum Biotechnologies
(NASDAQ:ADVM)
$1.18
00
At close: Jul 1
$1.18
00
PreMarket: 4:00PM EDT
Day High/Low- - -
52 Week High/Low0.8 - 3.66
Open / Close- / -
Float / Outstanding86.8M / 98.8M
Vol / Avg.- / 1.2M
Mkt Cap116.5M
P/E-
50d Avg. Price1
Div / Yield-
Payout Ratio-
EPS-0.38
Total Float86.8M

Adverum Biotechnologies (NASDAQ:ADVM), Quotes and News Summary

Adverum Biotechnologies (NASDAQ: ADVM)

Day High/Low- - -
52 Week High/Low0.8 - 3.66
Open / Close- / -
Float / Outstanding86.8M / 98.8M
Vol / Avg.- / 1.2M
Mkt Cap116.5M
P/E-
50d Avg. Price1
Div / Yield-
Payout Ratio-
EPS-0.38
Total Float86.8M
load more
Sector: Health Care.Industry: Biotechnology
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.380
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Adverum Biotechnologies Questions & Answers

Q
How do I buy Adverum Biotechnologies (ADVM) stock?
A

You can purchase shares of Adverum Biotechnologies (NASDAQ: ADVM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Adverum Biotechnologies's (ADVM) competitors?
Q
What is the target price for Adverum Biotechnologies (ADVM) stock?
A

The latest price target for Adverum Biotechnologies (NASDAQ: ADVM) was reported by Chardan Capital on Friday, July 23, 2021. The analyst firm set a price target for 3.00 expecting ADVM to rise to within 12 months (a possible 154.24% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Adverum Biotechnologies (ADVM)?
A

The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $1.18 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Adverum Biotechnologies (ADVM) pay a dividend?
A

There are no upcoming dividends for Adverum Biotechnologies.

Q
When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?
A

Adverum Biotechnologies’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Adverum Biotechnologies (ADVM) going to split?
A

There is no upcoming split for Adverum Biotechnologies.

Q
What sector and industry does Adverum Biotechnologies (ADVM) operate in?
A

Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.